Increasing ‘Customer Value’ is the new battleground for life science companies, and with good reason.
The unsustainable growth in healthcare costs means life science companies need to develop a greater return for the investments made in them.
The most common way life science companies are responding to this challenge is to optimise the positioning and pricing of their product portfolio. But as budgets become progressively stretched more value will be required.
Our new peer-reviewed white paper closely examines the dynamics of the situation by investigating why change is needed and outlining practical ways life science companies can effectively evolve in current and future market environments.
This paper will open a conversation about what customer value really means and how organisations can make practical changes to move towards a more sustainable relationship with healthcare.